Skip to Content

GE HealthCare Technologies Inc.

Company Name GE HealthCare Technologies Inc.
Stock Symbol GEHC

Submit Your Information

If you suffered a loss on your GE HealthCare Technologies Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

Shares Purchased

Number of Shares Buy Date Price Per Share Add

Shares Sold

Number of Shares Sell Date Price Per Share Add

Background

On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. Among other items, GE HealthCare reported adjusted earnings per share of $0.99 and cut its full-year 2026 adjusted EPS guidance to a range of $4.80 to $5.00, down from prior guidance of $4.95 to $5.15.

During the associated earnings call, management disclosed “profit performance in the first quarter . . . was impacted by a recall associated with a PDx supplier” and that “[y]ear-over-year margin performance was also impacted by declines in PCS and the PDx supplier issue.

On this news, the price of GE HealthCare shares declined by $9.01 per share, or 13.2%,  to close at $59.49 per share on April 29, 2026.

Submit Your Information